This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Respiratory
Respiratory
Tyrosine kinase inhibitor ‘reduces IPF lung decline’
Enrolment begins for Phase 3 COPD drug trial
NICE: ‘Great uncertainty’ lingers over COPD drug
EC approves Votubia® for tuberous sclerosis
NICE releases new quality standard on COPD
New microarray test for cystic fibrosis detection
NVA237 similar to tiotropium in COPD treatment
EU respiratory organisations call for COPD strategy
Management of chronic obstructive pulmonary disease
Phase III study shows improvements in lung function
Pulmonary arterial hypertension data presented
Nosocomial pneumonia treatment receives positive opinion
« Previous
1
…
15
16
17
18
19
…
28
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: